• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

China is promoting coronavirus treatments based on unproven traditional medicines.

作者信息

Cyranoski David

出版信息

Nature. 2020 May 6. doi: 10.1038/d41586-020-01284-x.

DOI:10.1038/d41586-020-01284-x
PMID:32376938
Abstract
摘要

相似文献

1
China is promoting coronavirus treatments based on unproven traditional medicines.中国正在推广基于未经证实的传统药物的新冠病毒治疗方法。
Nature. 2020 May 6. doi: 10.1038/d41586-020-01284-x.
2
[Analysis of property and efficacy of traditional Chinese medicine in staging revention and treatment of coronavirus disease 2019].[中医药在新型冠状病毒肺炎分期防治中的特性与疗效分析]
Zhongguo Zhong Yao Za Zhi. 2020 Mar;45(6):1253-1258. doi: 10.19540/j.cnki.cjcmm.20200225.501.
3
Antiviral mechanisms of candidate chemical medicines and traditional Chinese medicines for SARS-CoV-2 infection.针对 SARS-CoV-2 感染的候选化学药物和中药的抗病毒机制。
Virus Res. 2020 Sep;286:198073. doi: 10.1016/j.virusres.2020.198073. Epub 2020 Jun 24.
4
Structure-based lead optimization of herbal medicine rutin for inhibiting SARS-CoV-2's main protease.基于结构的中草药芦丁抑制 SARS-CoV-2 主蛋白酶的先导优化。
Phys Chem Chem Phys. 2020 Nov 21;22(43):25335-25343. doi: 10.1039/d0cp03867a. Epub 2020 Nov 3.
5
Chinese herbal medicine: Fighting SARS-CoV-2 infection on all fronts.中草药：全方位抗击 SARS-CoV-2 感染。
J Ethnopharmacol. 2021 Apr 24;270:113869. doi: 10.1016/j.jep.2021.113869. Epub 2021 Jan 21.
6
Traditional herbal medicines to overcome stress, anxiety and improve mental health in outbreaks of human coronaviruses.传统草药可克服人类冠状病毒爆发时的压力、焦虑和改善心理健康。
Phytother Res. 2021 Mar;35(3):1237-1247. doi: 10.1002/ptr.6888. Epub 2020 Dec 22.
7
Review on the potential action mechanisms of Chinese medicines in treating Coronavirus Disease 2019 (COVID-19).中药治疗 2019 年冠状病毒病（COVID-19）的潜在作用机制研究进展。
Pharmacol Res. 2020 Aug;158:104939. doi: 10.1016/j.phrs.2020.104939. Epub 2020 May 21.
8
Traditional Chinese Medicine in the Treatment of Patients Infected with 2019-New Coronavirus (SARS-CoV-2): A Review and Perspective.中药治疗 2019 年新型冠状病毒（SARS-CoV-2）感染患者：综述与展望。
Int J Biol Sci. 2020 Mar 15;16(10):1708-1717. doi: 10.7150/ijbs.45538. eCollection 2020.
9
Potential drugs for the treatment of the novel coronavirus pneumonia (COVID-19) in China.中国治疗新型冠状病毒肺炎（COVID-19）的潜在药物。
Virus Res. 2020 Sep;286:198057. doi: 10.1016/j.virusres.2020.198057. Epub 2020 Jun 9.
10
Epigallocatechin-3-gallate, an active ingredient of Traditional Chinese Medicines, inhibits the 3CLpro activity of SARS-CoV-2.表没食子儿茶素没食子酸酯，一种中药的有效成分，抑制 SARS-CoV-2 的 3CLpro 活性。
Int J Biol Macromol. 2021 Apr 15;176:1-12. doi: 10.1016/j.ijbiomac.2021.02.012. Epub 2021 Feb 4.

引用本文的文献

1
Characteristics and result reporting of registered COVID-19 clinical trials of Chinese and Indian traditional medicine: A comparative analysis.中国和印度传统医学注册的COVID-19临床试验的特征与结果报告：一项比较分析。
Front Med (Lausanne). 2023 Feb 17;10:1118269. doi: 10.3389/fmed.2023.1118269. eCollection 2023.
2
Kidney tonifying traditional Chinese medicine: Potential implications for the prevention and treatment of osteoporosis.补肾中药：对骨质疏松症防治的潜在意义
Front Pharmacol. 2023 Jan 9;13:1063899. doi: 10.3389/fphar.2022.1063899. eCollection 2022.
3
Planetary health & COVID-19: A multi-perspective investigation.
行星健康与新冠疫情：多视角调查
One Health. 2022 Dec;15:100416. doi: 10.1016/j.onehlt.2022.100416. Epub 2022 Jul 22.
4
Supramolecular assemblies based on natural small molecules: Union would be effective.基于天然小分子的超分子组装体：联合使用可能有效。
Mater Today Bio. 2022 Jun 15;15:100327. doi: 10.1016/j.mtbio.2022.100327. eCollection 2022 Jun.
5
Cochrane systematic reviews on traditional Chinese medicine: What matters-the quantity or quality of evidence?考科蓝关于中医药的系统评价：关键在于证据的数量还是质量？
Phytomedicine. 2022 Apr;98:153921. doi: 10.1016/j.phymed.2021.153921. Epub 2022 Jan 10.
6
COVID-19 and Traumatic Brain Injury (TBI); What We Can Learn From the Viral Pandemic to Better Understand the Biology of TBI, Improve Diagnostics and Develop Evidence-Based Treatments.新型冠状病毒肺炎与创伤性脑损伤（TBI）；我们能从这场病毒大流行中学到什么，以更好地理解TBI的生物学机制、改进诊断方法并开发循证治疗方案。
Front Neurol. 2021 Dec 20;12:752937. doi: 10.3389/fneur.2021.752937. eCollection 2021.
7
Event-Based Surveillance of Poisonings and Potentially Hazardous Exposures over 12 Months of the COVID-19 Pandemic.基于事件的 COVID-19 大流行期间 12 个月内中毒和潜在危险暴露监测。
Int J Environ Res Public Health. 2021 Oct 22;18(21):11133. doi: 10.3390/ijerph182111133.
8
COVID-19 home remedies and myths becoming a hazardous health infodemic?新冠疫情的家庭疗法与谣言正演变成一场有害的健康信息疫情？
Jamba. 2021 Sep 30;13(1):1115. doi: 10.4102/jamba.v13i1.1115. eCollection 2021.
9
Attitudes of Chinese immigrants in Canada towards the use of Traditional Chinese Medicine for prevention and management of COVID-19: a cross-sectional survey during the early stages of the pandemic.在新冠疫情初期的一项横断面调查中，探究加拿大华裔对使用中医药进行新冠预防和管理的态度。
BMJ Open. 2021 Sep 14;11(9):e051499. doi: 10.1136/bmjopen-2021-051499.
10
Glycyrrhizic Acid: A Natural Plant Ingredient as a Drug Candidate to Treat COVID-19.甘草酸：一种作为治疗新冠肺炎候选药物的天然植物成分。
Front Pharmacol. 2021 Jul 9;12:707205. doi: 10.3389/fphar.2021.707205. eCollection 2021.